Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer

Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer

<p>Abstract</p> <p>Background</p> <p>Stable disease (SD) has ambiguous clinical significance for patients according to the dominant Response Evaluation Criteria in Solid Tumours (RECIST). The primary aims of the study were: (1) to clarify the clinical significance of SD...

Full description

Bibliographic Details
Main Authors: Li Songbai, Zhang Jingdong, Hu Xuejun, Yu Ping, Zhao Mingfang, Jin Bo, Teng Yuee, He Lijie, Gao Yaling, Liu Yunpeng
Format: Article
Language:English
Published: BMC 2010-12-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/10/681

Internet

http://www.biomedcentral.com/1471-2407/10/681

Similar Items